iBio, Inc.
Public company- Headquarters
- NEW YORK, New York
- Ticker
- IBIO
- CIK
- 0001420720
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Aug 4, 2026
Executive appointmentCMO appointed: Molly Carr, M.D.
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CMOMolly Carr, M.D. | Aug 4, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- PFIZER INC
CFO appointed: Cecile Guegan
- ROCKET PHARMACEUTICALS, INC.
WARN notice: Cranbury, NJ
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Executive appointment
CMO appointed: Molly Carr, M.D.
Molly Carr, M.D. was named Chief Medical Officer of iBio, Inc., effective July 31, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 4, 2026Role: Chief Medical Officer
layoffs from Jan 2, 2023
WARN noticeWARN notice: Bryan, TX
iBio CDMO filed a WARN notice with the Texas WARN list on Oct 31, 2022 covering 50 workers in Bryan. The layoffs take effect on Jan 2, 2023.
Source: Texas WARN list, filed Oct 31, 2022Site: Bryan, TX
Workers affected: 50
Last verified Nov 8, 2026